Abstract
Objective To investigate the expression of apoptosis regulatory factor Survivin and caspase-3 in epithelial ovarian tumor and its clinical significance.Methods The expression of proteins Survivin and caspase-3 in 40 cases of epithelial ovarian tumor,10 cases of borderline epithelial ovarian tumora and 10 cases of benign ethelial tumor were detected by immunohistochemistry; then the clinical and pathological features were analyzed.Results There was a negative correlation of Survivin and caspase-3 expression in epithelial ovarian tumor; the expression rate of Survivin in epithelial ovarian cancer was 72.5% (29/40),and it was higher than that in epithelial ovarian tumor and borderline epithelial ovarian tumor(P < 0.05).The expression rate of caspase-3 in epithelial ovarian cancer was 0.5%(2/40),and it was more lower than that in epithelial ovarian tumor and borderline epithelial ovarian tumor(P <0.01).Conclusions The expression of caspase-3 is inhibited by Survivin,which results in the ovarian cancer cells multiplication,apoptosis obstruction and tumor generation; The expression of Survivin gene happens in the early stage of ovarian cancer malignant transformation; The expression of Survivin is closely correlated with tumor cell differentiation and proliferation,and its high expression can be the identification marker of unfavourable prognosis; The expression level of caspase-3 in ovarian cancer is quite low,which makes it a new index to identify the benign and malignant ovarian tumor; The qualitative and quantitative analysis of Survivin,caspase-3 and PCNA may become the index of curative effect of drugs. Key words: Survivin; Caspase-3; Ovarian cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.